课题基金 / 基金详情

SUMO Fusions to Enhance Expression and Secretion of Protiens

SUMO Fusions to Enhance Expression and Secretion of Protiens
SUMO 融合增强蛋白质的表达和分泌
批准号:
7053070
负责人:
Tauseef R. Butt
金额:
$53.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2008-02-28

项目摘要

项目成果

Tauseef R. Butt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): As more proteins are identified from the genome-sequencing projects, there is an increasing need for reliable and cost efficient means for expression and purification of proteins of academic and clinical importance. LifeSensors has developed a novel SUMO-fusion system to enhance expression, and solubility of a wide variety of proteins in E. coli, and to facilitate the downstream purification of the protein via an affinity tag attached to SUMO. An important feature of the system is the protease that cleaves the SUMO-fusion from expressed proteins. The removal of the fusion leaves no N-terminal overhang, so that any desired amino acid can be cloned at the N-terminus of the expressed protein. Several research or therapeutically important proteins either are not expressed well in bacteria or are inefficiently secreted. Recent data from the Protein Structure Initiative suggest that production of correctly folded protein is a bottleneck for success in our quest for Structural Genomics. In phase I, we proposed to exploit the chaperoning properties of SUMO to enhance expression and secretion of proteins in E. coli. Recognizing the well-known protein secretion properties of Bacillus subtilis and Lactococcus lactis we also proposed to test the role of N-terminal of SUMO in secretion of protein in these gram-positive organisms. Lactococcus lactis is well known for its secretory properties and widely used in the food industry, and yet this bacteria has not been well exploited for protein secretion in the biopharmaceutical industry. Our phase I data suggest that while E. coli is good for intracellular expression, it is not the best host for protein secretion. Lactococus lactis has emerged as the most suitable host for secretion and production of large quantities of proteins. In this phase II, LifeSensors proposes a plan to build on its success with L. lactis to test a wide variety of difficult to express protein and further validate the usefulness and role of SUMO and L. lactis as a host for protein secretion. Development of an efficient secretory system in L. lactis that allows production of correctly folded, difficult to express protein will open the bottleneck for Structural Genomics. It will also create an inexpensive platform for endotoxin free protein production that will help the biopharmaceutical industry in the post-genomic era.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of chain selective polyubiquitin markers as early detectors of Parkinson’s and Alzheimer’s Disease
  • 批准号:
    9406658
  • 项目类别:
  • 资助金额:
    $19.03万
  • 财政年份:
    2017
  • 负责人:
    Tauseef R. Butt
  • 依托单位:
Ubiquitin Proteasome System and Molecular Signatures of Alzheimer's Disease
  • 批准号:
    10002167
  • 项目类别:
  • 资助金额:
    $78.53万
  • 财政年份:
    2017
  • 负责人:
    Tauseef R. Butt
  • 依托单位:
Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease
  • 批准号:
    9789790
  • 项目类别:
  • 资助金额:
    $77.97万
  • 财政年份:
    2016
  • 负责人:
    Tauseef R. Butt
  • 依托单位:
A novel fluorescent assay for ubiquitin isopeptide bond cleavage
  • 批准号:
    7909624
  • 项目类别:
  • 资助金额:
    $23.5万
  • 财政年份:
    2010
  • 负责人:
    Tauseef R. Butt
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: